在AMPA受体中,所有的竞争和抑制
W Dylan Hale1,2, Alejandra Montaño Romero1,2, Cuauhtemoc U Gonzalez3,4
1Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nature structural & molecular biology
|June 4, 2024
概括
负调节剂,如GYKI-52466,通过改变它们的结构来抑制α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体. 这阻止了激活和正调制,提供了治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 激发性神经传递依赖于α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体. 激发性神经传递依赖于α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体. 激发性神经传递依赖于α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体. 激发性神经传递依赖于α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体. 激发性神经传递依赖于α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体. 激发性神经传递依赖于α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体.
- 负调节剂 (NAM) 通过抑制AMPA受体功能,为神经疾病提供治疗潜力.
- 通过NAM与正调节器 (PAM) 竞争的确切机制尚不清楚.
研究的目的:
- 阐明NAMs抑制AMPA受体激活的结构机制.
- 了解NAM如何阻止PAM调节AMPA受体功能.
- 为设计针对AMPA受体的新疗法提供结构基础.
主要方法:
- 使用冷电子显微镜可视化AMPA受体.
- 在谷氨酸,一个NAM (GYKI-52466) 和一个PAM (循环亚胺) 的存在下捕获结构.
- 进行了竞争性结合试验,以评估全调节.
主要成果:
- 通过GYKI-52466的Allosteric抑制诱导一个独特的AMPA受体状态.
- GYKI-52466与离子通道项圈结合,从离子通道中解离联体结合域.
- 这种结构重组破坏了环亚胺结合部位,防止了积极的全调节.
结论:
- 通过GYKI-52466的菌抑制从根本上改变了AMPA受体的形状.
- 这些发现揭示了NAM如何抑制AMPA受体和防止PAM增强的机制.
- 这项研究为合理的药物设计提供了一个结构框架,该框架针对神经系统疾病中的AMPA受体.
相关概念视频
01:08Allosteric Regulation
57.9K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.9K
01:58Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:30Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
00:46Feedback Inhibition
53.8K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.8K